Dyslipidemia is an abnormal blood fat level, including cholesterol and triglycerides. A common term used for this condition is cholesterol. This multicenter, open-label extension (OLE) study was designed to assess the extended long-term safety of the test drug in subjects who have completed the previous FOURIER trial.
Dyslipidemia clinical trials are underway in Little River, South Carolina, to help find potential treatments for dyslipidemia.
Be a part of innovative research that could lead to life-saving treatments and improved healthcare for yourself and future generations.
Get the chance to try a new medication, device, or therapy before it’s widely available.
Deepen your understanding of your health condition and potentially experience direct benefits from the tested intervention.
Clinical trials are research studies that test the impact of new or existing medical interventions on human volunteers. These interventions can be anything from medications (think new drugs, vaccines, or therapies) to medical devices (pacemakers, stents, surgical techniques) and even treatment approaches (new surgical procedures, behavioral therapies). The entire process is meticulously designed to assess the intervention’s safety, effectiveness, dosage, and potential side effects.
